203 related articles for article (PubMed ID: 32612137)
1. Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach.
García MJ; Pascual M; Del Pozo C; Díaz-González A; Castro B; Rasines L; Crespo J; Rivero M
Sci Rep; 2020 Jul; 10(1):10731. PubMed ID: 32612137
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
Attauabi M; Zhao M; Bendtsen F; Burisch J
Inflamm Bowel Dis; 2021 May; 27(6):927-939. PubMed ID: 32628745
[TBL] [Abstract][Full Text] [Related]
4. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
[TBL] [Abstract][Full Text] [Related]
5. Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies.
Agrawal M; Shah S; Patel A; Pinotti R; Colombel JF; Burisch J
J Autoimmun; 2019 Dec; 105():102303. PubMed ID: 31351784
[TBL] [Abstract][Full Text] [Related]
6. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.
Akiyama S; Fukuda S; Steinberg JM; Suzuki H; Tsuchiya K
World J Gastroenterol; 2022 Jul; 28(25):2843-2853. PubMed ID: 35978883
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study.
Attauabi M; Poulsen A; Theede K; Pedersen N; Larsen L; Jess T; Rosager Hansen M; Verner-Andersen MK; V Haderslev K; Berg Lødrup A; Molazahi A; Neumann A; Wase A; Seidelin JB; Burisch J
J Crohns Colitis; 2021 Apr; 15(4):540-550. PubMed ID: 33035299
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
Attauabi M; Wewer MD; Bendtsen F; Seidelin JB; Burisch J
Inflamm Bowel Dis; 2022 Nov; 28(11):1756-1765. PubMed ID: 35134921
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study.
Vernero M; Saibeni S; Scalvini D; Cicalini C; Chiarello L; Nardi S; Ribaldone DG; Bezzio C
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398332
[No Abstract] [Full Text] [Related]
11. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
Vanaclocha F; Crespo-Erchiga V; Jiménez-Puya R; Puig L; Sánchez-Carazo JL; Ferrán M; Sancho C; Juliá B; Cea-Calvo L; Marín-Jiménez I; García-Vicuña R;
Actas Dermosifiliogr; 2015; 106(1):35-43. PubMed ID: 25091923
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic differences in autoimmune disease prevalence in US claims/EHR data.
Goonesekera SD; Dey S; Thakur S; Davila EP
Am J Manag Care; 2024 Jan; 30(1):e4-e10. PubMed ID: 38271568
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations.
Bezzio C; Della Corte C; Vernero M; Di Luna I; Manes G; Saibeni S
Therap Adv Gastroenterol; 2022; 15():17562848221115312. PubMed ID: 35924080
[TBL] [Abstract][Full Text] [Related]
14. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
Conway G; Velonias G; Andrews E; Garber JJ; Yajnik V; Ananthakrishnan AN
Aliment Pharmacol Ther; 2017 Mar; 45(6):814-823. PubMed ID: 28105709
[TBL] [Abstract][Full Text] [Related]
15. Trends in Optic Neuritis Incidence and Prevalence in the UK and Association With Systemic and Neurologic Disease.
Braithwaite T; Subramanian A; Petzold A; Galloway J; Adderley NJ; Mollan SP; Plant GT; Nirantharakumar K; Denniston AK
JAMA Neurol; 2020 Dec; 77(12):1514-1523. PubMed ID: 33017023
[TBL] [Abstract][Full Text] [Related]
16. Comorbid immune-mediated diseases in inflammatory bowel disease: a nation-wide population-based study.
Park SW; Kim TJ; Lee JY; Kim ER; Hong SN; Chang DK; Yang M; Kim S; Shin MH; Kim YH
Aliment Pharmacol Ther; 2019 Jan; 49(2):165-172. PubMed ID: 30506945
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.
Fernández-Gutiérrez B; Perrotti PP; Gisbert JP; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; García-Sánchez V; Panés J; Fonseca E; Blanco F; Rodríguez-Moreno J; Carreira P; Julià A; Marsal S; Rodriguez-Rodriguez L;
Medicine (Baltimore); 2017 Jun; 96(26):e7308. PubMed ID: 28658137
[TBL] [Abstract][Full Text] [Related]
18. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
19. [Immune-Mediated Inflammatory Diseases and accompanying comorbidities].
Majdan M
Wiad Lek; 2016; 69(4):611-615. PubMed ID: 27941197
[TBL] [Abstract][Full Text] [Related]
20. [Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain].
Saro Gismera C; Riestra Menéndez S; Milla Crespo A; Sánchez Fernández R; Lacort Fernández M; Argüelles Fernández G; Chovac Z; Florido Mancheño JI; Antón Magarzo JL; Altadill Arregui A; Vizoso F; Pineda García E; Fernández de Ocariz Archs E; Albert Colomer J; García Pérez J; López Rivas L; Lombraña JL
An Med Interna; 2003 Jan; 20(1):3-9. PubMed ID: 12666301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
